(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 48.96%33.19B | 145.63%113.74B | 138.60%85.54B | 155.37%49.43B | 75.92%22.28B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B | 14.30%67.13B |
Operating income | 48.96%33.19B | 145.63%113.74B | 138.60%85.54B | 155.37%49.43B | 75.92%22.28B | -31.02%46.31B | -31.72%35.85B | -44.24%19.35B | -5.45%12.67B | 14.30%67.13B |
Operating expenses | -30.90%-31.68B | -43.73%-80.96B | -26.10%-24.2B | 5.23%-56.33B | -7.63%-19.2B | |||||
Gross profit | 178.33%1.51B | 122.34%4.58B | 70.54%-1.92B | -195.14%-20.48B | -47.07%-6.53B | |||||
Selling expenses | -56.18%-1.37B | -249.46%-2.93B | -86.61%-3.11B | -335.06%-1.34B | -57.76%-874M | 25.62%-839M | 28.11%-1.67B | 60.16%-308M | 18.05%-554M | 28.15%-1.13B |
Administrative expenses | -7.96%-854M | ---- | 5.47%-2.44B | ---- | 1.62%-791M | ---- | -2.06%-2.58B | ---- | -13.88%-804M | ---- |
Research and development expenses | 11.49%-77M | ---- | -5.83%-218M | ---- | -16.00%-87M | ---- | -7.29%-206M | ---- | -70.45%-75M | ---- |
Profit from asset sales | 140.00%12M | ---- | -25.00%9M | ---- | -58.33%5M | ---- | --12M | ---- | 1,300.00%12M | ---- |
Employee expense | ---- | -15.27%-23.61B | ---- | -13.24%-10.92B | ---- | 2.73%-20.49B | ---- | 9.90%-9.65B | ---- | -1.12%-21.06B |
Depreciation and amortization | ---- | -14.73%-25.02B | ---- | -14.54%-12.21B | ---- | 3.99%-21.81B | ---- | 4.98%-10.66B | ---- | -2.08%-22.72B |
Revaluation surplus | 600.00%5M | 41.67%-7M | 86.67%-2M | 83.33%-1M | 80.00%-1M | -9.09%-12M | -114.29%-15M | -300.00%-6M | -141.67%-5M | 57.69%-11M |
-Changes in the fair value of financial assets | ---- | 41.67%-7M | ---- | 83.33%-1M | ---- | -9.09%-12M | ---- | -300.00%-6M | ---- | 57.69%-11M |
-Changes in the fair value of other assets | 600.00%5M | ---- | 86.67%-2M | ---- | 80.00%-1M | ---- | -114.29%-15M | ---- | -141.67%-5M | ---- |
Impairment and provision | --0 | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 | 76.85%-50M |
-Other impairment is provision | --0 | 42.40%-72M | -633.33%-44M | -450.00%-44M | --0 | -150.00%-125M | -20.00%-6M | -166.67%-8M | --0 | 76.85%-50M |
Special items of operating profit | 50.49%1.39B | -84.90%-64.01B | 63.85%3.83B | -90.42%-27.51B | 9.62%923M | 2.96%-34.62B | -38.34%2.34B | 17.40%-14.45B | -39.21%842M | -28.92%-35.68B |
Operating profit | 119.37%544M | 93.92%-1.92B | 110.47%2.38B | 83.48%-2.6B | 60.68%-2.81B | -133.67%-31.59B | -171.63%-22.73B | -187.16%-15.72B | -58.44%-7.14B | 2.33%-13.52B |
Financing income | ---- | -3.32%495M | ---- | 30.95%275M | ---- | -73.85%512M | ---- | -77.89%210M | ---- | -26.39%1.96B |
Financing cost | -16.16%-1.42B | 20.96%-6.98B | 23.15%-5.62B | -4.25%-4.66B | -4.55%-1.22B | -51.98%-8.83B | -125.94%-7.31B | -61.17%-4.47B | -4.29%-1.17B | -11.49%-5.81B |
Share of profits of associates | ---- | 174.19%115M | ---- | 157.14%18M | ---- | -59.79%-155M | ---- | -69.57%7M | ---- | -18.29%-97M |
Share of profit from joint venture company | ---- | 126.00%13M | ---- | 80.00%-6M | ---- | -13.64%-50M | ---- | -233.33%-30M | ---- | -238.46%-44M |
Special items of earning before tax | 229.41%56M | ---- | 72.28%174M | ---- | -68.52%17M | ---- | -30.82%101M | ---- | 63.64%54M | ---- |
Earning before tax | 79.65%-816M | 79.36%-8.28B | 89.77%-3.06B | 65.16%-6.97B | 51.41%-4.01B | -129.05%-40.11B | -161.31%-29.94B | -174.66%-20B | -47.59%-8.25B | -6.22%-17.51B |
Tax | -342.31%-115M | -237.70%-336M | 6,928.57%492M | 1,752.38%389M | -62.50%-26M | -94.23%244M | -99.76%7M | -98.88%21M | -101.08%-16M | 7.69%4.23B |
After-tax profit from continuing operations | 76.93%-931M | 78.39%-8.61B | 91.41%-2.57B | 67.07%-6.58B | 51.19%-4.04B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B | -5.76%-13.28B |
After-tax profit from non-continuing business | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- |
Earning after tax | 76.93%-931M | 78.39%-8.61B | 91.41%-2.57B | 67.07%-6.58B | 51.19%-4.04B | -200.14%-39.87B | -248.88%-29.93B | -270.03%-19.97B | -101.05%-8.27B | -5.76%-13.28B |
Minority profit | 34.69%-128M | 82.26%-446M | 102.04%37M | 73.51%-328M | 61.49%-196M | -134.95%-2.51B | -334.93%-1.82B | -551.58%-1.24B | -65.26%-509M | -47.59%-1.07B |
Profit attributable to shareholders | 79.09%-803M | 78.13%-8.17B | 90.73%-2.61B | 66.65%-6.25B | 50.52%-3.84B | -205.85%-37.36B | -244.47%-28.12B | -259.75%-18.74B | -103.94%-7.76B | -3.19%-12.21B |
Basic earnings per share | 76.47%-0.04 | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 | -1.39%-0.73 |
Diluted earnings per share | 76.47%-0.04 | 81.31%-0.37 | 92.15%-0.117 | 71.72%-0.28 | 58.54%-0.17 | -171.23%-1.98 | -198.96%-1.4897 | -209.38%-0.99 | -78.26%-0.41 | -1.39%-0.73 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data